Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Alabama at Birmingham
Mayo Clinic
Pfizer
Turning Point Therapeutics, Inc.
Melanoma and Skin Cancer Trials Limited